CME: The Role of Allergy Testing to Achieve Personalized Treatment Goals for Allergic Rhinitis & Asthma

The Role of Allergy Testing to Achieve Personalized Treatment Goals for Allergic Rhinitis & Asthma

The Role of Allergy Testing to Achieve Personalized Treatment Goals for Allergic Rhinitis & Asthma

Learn why allergy testing is crucial to the successful management of AR and asthma and its appropriate use to improve patient outcomes.

Available credits: 0.25

Time to complete: 15 minutes


Valid until:

Take Post-Test

If you’ve already completed the activity.

  • Overview

    Allergic rhinitis (AR) and asthma are common allergic respiratory conditions.  In fact, AR is a major factor in the development of asthma.  Medical costs associated with these two conditions are high, but can be reduced considerably when following evidence-based diagnosis and treatment guidelines, which include allergy testing and avoidance of relevant allergens. 

    The goal of this CME activity is to help clinicians understand the rationale for allergy testing for people with AR and asthma and incorporate the results from allergy testing into a comprehensive evidence-based treatment approach.

  • Disclosure of Conflicts of Interest

    In accordance with the ACCME Standards for Commercial Support, The Omnia-Prova Education Collaborative (TOPEC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. TOPEC resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

    John J. Russell, MD
    Director Family Medicine Residency
    Abington Memorial Hospital
    Abington, PA

    Financial Disclosure:
    Dr. Russell is part of the speakers bureau for Sanofi Pasteur.


    Henry A. Wojtczak, MD
    Pediatric Pulmonology
    Naval Medical Center San Diego
    San Diego, CA

    Financial Disclosure:
    Dr. Wojtczak receives consulting fees from Vertex Pharmaceuticals and is a speaker for non-CME services for AstraZeneca, Chiesi, Gilead Sciences, Thermo Fisher Scientific, Vertex Pharmaceuticals. 


    • Sean T. Barrett has nothing to disclose.
    • Carole Drexel, PhD, CHCP has nothing to disclose.
    • Ann Early has nothing to disclose.
    • Deborah Lee, BSN, RN-BC, CCRP has nothing to disclose.
    • Jessica McGrory has nothing to disclose.
    • Lawrence Sherman has nothing to disclose.
  • Learning Objectives

    The goal of this activity is for clinicians to improve interprofessional collaboration and teamwork as a means of improving healthcare delivery for patient with AR or asthma.

    • Describe the burden of AR and asthma in terms of impact on quality of life and costs to the healthcare system.
    • Develop a personalized allergy testing approach for individual patients based on a clinical history.
    • Incorporate the results from allergy testing into an interprofessional, team-delivered, comprehensive, evidence-based management strategy for patients with allergic rhinitis or asthma.

  • Target Audience

    This activity is intended for primary care providers (family/internal medicine), pediatricians, pulmonologists and other healthcare professionals who are involved in the management of patients with AR and asthma.

  • Accreditation and Credit Designation Statements

    The Omnia-Prova Education Collaborative, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    The Omnia-Prova Education Collaborative, Inc. designates this enduring material for a maximum of .25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Provider

    Prova Education designs educational activities based on evidence-based medicine, needs and gaps analyses, learner feedback, and more. Its mission is to serve as an innovative and relevant resource for clinical content and educational interventions across a broad spectrum of specialties.

  • Commercial Support

    This activity is supported by an independent educational grant from Phadia US Inc., a part of Thermo Fisher Scientific.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of TOPEC and Prova Education. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of Prova Education you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.

    Reproduction Prohibited

    Reproduction of this material is not permitted without written permission from the copyright owner.

  • System Requirements

    Our site requires a computer, tablet or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/cable). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Internet Explorer, Microsoft Edge, Chrome, Firefox or Safari. Users accustomed to IE8, IE9 IE10 are advised to update their browsers for the best experience.

Facebook Comments


We’re glad to see you’re enjoying Prova Education…
but how about a more personalized experience?

Register for free